Tesla sales fall across Europe again as BYD surges; Ryanair to appeal €256m fine from Italy’s competition authority – business live

Rolling coverage of the latest economic and financial news

Shares in Novo Nordisk have jumped 7.5% this morning after it won approval from the U.S. Food and Drug Administration for the first weight-loss drug to be administered orally.

Yesterday, US regulators gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity.